StockData
Cytokinetics Inc logo

Cytokinetics Inc (CYTK) stock

CYTKNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 4, 2026Score 4/30
$51.65−1.52 (-2.86%)

Close on Nov 17, 2026Market cap $7.18BP/E –Yield –

Cytokinetics cash

Cash and short-term investments held at the end of each period.

Cytokinetics's cash was $1.70B at Jun 30, 2026. For fiscal 2025 it was $1.20B, up 0.0% from the year before. Over ten years it grew 26.8% a year on average. The highest annual figure on record is $1.20B in fiscal 2024.

Annual cash

PeriodPeriod endValueChange
FY2025Dec 31, 2025$1.20B0.0%
FY2024Dec 31, 2024$1.20B+83.1%
FY2023Dec 31, 2023$655.40M-21.0%
FY2022Dec 31, 2022$829.30M+33.0%
FY2021Dec 31, 2021$623.70M+24.5%
FY2020Dec 31, 2020$501.00M+87.1%
FY2019Dec 31, 2019$267.80M+34.8%
FY2018Dec 31, 2018$198.70M-30.4%
FY2017Dec 31, 2017$285.40M+74.1%
FY2016Dec 31, 2016$163.90M+46.9%
FY2015Dec 31, 2015$111.60M+34.1%
FY2014Dec 31, 2014$83.20M+3.7%
FY2013Dec 31, 2013$80.20M+8.4%
FY2012Dec 31, 2012$74.00M+51.0%
FY2011Dec 31, 2011$49.00M-31.6%
FY2010Dec 31, 2010$71.64M+180.3%
FY2009Dec 31, 2009$25.56M-38.9%
FY2008Dec 31, 2008$41.82M–

Quarterly cash

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026$1.70B+70.0%
Q1 FY2026Mar 31, 2026$1.10B0.0%
Q4 FY2025Dec 31, 2025$1.20B0.0%
Q3 FY2025Sep 30, 2025$1.30B0.0%
Q2 FY2025Jun 30, 2025$1.00B-28.6%
Q1 FY2025Mar 31, 2025$1.10B+73.4%
Q4 FY2024Dec 31, 2024$1.20B+83.1%
Q3 FY2024Sep 30, 2024$1.30B+134.4%
Q2 FY2024Jun 30, 2024$1.40B+136.2%
Q1 FY2024Mar 31, 2024$634.30M-10.0%
Q4 FY2023Dec 31, 2023$655.40M-21.0%
Q3 FY2023Sep 30, 2023$554.70M-36.1%
Q2 FY2023Jun 30, 2023$592.60M+1.1%
Q1 FY2023Mar 31, 2023$704.40M+15.7%
Q4 FY2022Dec 31, 2022$829.30M+33.0%
Q3 FY2022Sep 30, 2022$867.66M+81.7%
Q2 FY2022Jun 30, 2022$586.03M+67.3%
Q1 FY2022Mar 31, 2022$608.97M+43.1%
Q4 FY2021Dec 31, 2021$623.70M+24.5%
Q3 FY2021Sep 30, 2021$477.64M+16.4%
Q2 FY2021Jun 30, 2021$350.30M+64.4%
Q1 FY2021Mar 31, 2021$425.58M+92.8%
Q4 FY2020Dec 31, 2020$501.00M+87.1%
Q3 FY2020Sep 30, 2020$410.26M+147.1%
Q2 FY2020Jun 30, 2020$213.06M+23.3%
Q1 FY2020Mar 31, 2020$220.71M+25.0%
Q4 FY2019Dec 31, 2019$267.80M+34.8%
Q3 FY2019Sep 30, 2019$166.04M-21.1%
Q2 FY2019Jun 30, 2019$172.87M-25.5%
Q1 FY2019Mar 31, 2019$176.62M-29.8%
Q4 FY2018Dec 31, 2018$198.70M-30.4%
Q3 FY2018Sep 30, 2018$210.31M-31.8%
Q2 FY2018Jun 30, 2018$231.94M-30.2%
Q1 FY2018Mar 31, 2018$251.45M-2.2%
Q4 FY2017Dec 31, 2017$285.40M+74.1%
Q3 FY2017Sep 30, 2017$308.20M+257.1%
Q2 FY2017Jun 30, 2017$332.10M–
Q1 FY2017Mar 31, 2017$257.20M–
Q4 FY2016Dec 31, 2016$163.90M–
Q3 FY2016Sep 30, 2016$86.30M–

More Cytokinetics figures

See a number that looks wrong?